Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma

New England Journal of Medicine

Volumn 352, Issue 23, 2005, Pages 2406-2412

  Shattuck, Trisha M ^a   Westra, William H ^b   Ladenson, Paul W ^c   Arnold, Andrew ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DNA; AR PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; THYROID CARCINOMA; THYROID TUMOR; TUMOR; X CHROMOSOME; CELL CLONE; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; MULTIPLE CANCER; PAPILLARY CARCINOMA; PATHOLOGY;

CARCINOMA, PAPILLARY; CHROMOSOMES, HUMAN, X; CLONE CELLS; DNA, NEOPLASM; DOSAGE COMPENSATION, GENETIC; FEMALE; HETEROZYGOTE; HUMANS; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; THYROID NEOPLASMS;

EID: 20344403102     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa044190     Document Type: Article

References (40)

1. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-11.
2. Grebe SK, Hay ID. Follicular cell-derived thyroid carcinomas. Cancer Treat Res 1997;89:91-140.
3. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990;60:557-63.
4. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994;54:2979-85.
5. Minoletti F, Butti MG, Coronelli S, et al. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosomes Cancer 1994;11:51-7.
6. Sozzi G, Bongarzone I, Miozzo M, et al. A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosomes Cancer 1994;9:244-50.
7. Pierotti MA, Bongarzone I, Borrello MG, et al. Rearrangements of TRK protooncogene in papillary thyroid carcinomas. J Endocrinol Invest 1995;18:130-3.
8. Pierotti MA, Vigneri P, Bongarzone I. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas. Recent Results Cancer Res 1998;154:237-47.
9. Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL. N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 1994;116:1010-6.
10. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003;95:625-7.
11. Fukushima T, Suzuki S, Mashiko M, et al. BRAF mutations in papillary carcinomas of the thyroid. Oncogene 2003;22:6455-7.
12. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003;63:1454-7.
13. Fagin JA. Challenging dogma in thyroid cancer molecular genetics - role of RET/PTC and BRAF in tumor initiation. J Clin Endocrinol Metab 2004;89:4264-6.
14. Iida F, Yonekura M, Miyakawa M. Study of intraglandular dissemination of thyroid cancer. Cancer 1969;24:764-71.
15. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 1976;43:207-15.
16. Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Annu 1985;20:1-44.
17. Tscholl-Ducommun J, Hedinger CE. Papillary thyroid carcinomas: morphology and prognosis. Virchows Arch A Pathol Anat Histol 1982;396:19-39.
18. Russell WO, Ibanez ML, Clark RL, White EC. Thyroid carcinoma classification, intraglandular dissemination, and clinicopathological study based upon whole organ section of 80 glands. Cancer 1963;16:1425-60.
19. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: a clinicopathologic study of 105 consecutive patients. Cancer 1992;70:1585-90.
20. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989;63:908-11.
21. Mazzaferri EL, Jhiang S. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28. [Erratum, Am J Med 1995;98:215.]
22. Ringel MD, Ladenson PW. Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004;11:97-116.
23. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998;83:4116-22.
24. Moniz S, Catarino AL, Marques AR, Cavaco B, Sobrinho L, Leite V. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation. Eur J Endocrinol 2002;146:27-33.
25. Pacini F, De Groot LJ. Thyroid cancer. In: De Groot LJ, ed. The thyroid and its diseases. (Accessed May 13, 2005, at http:// www.thyroidmanager.org/ Chapter18/18-nodu-cancer.htm.)
26. Williams GT, Wynford-Thomas D. How may clonality be assessed in human tumours? Histopathology 1994;24:287-92.
27. Fey MF, Tobler A. Tumour heterogeneity and clonality - an old theme revisited. Ann Oncol 1996;7:121-8.
28. Unger K, Zitzelsberger H, Salvatore G, et al. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 2004;89:4272-9.
29. Kim H, Piao Z, Park C, Chung WY, Park CS. Clinical significance of clonality in thyroid nodules. Br J Surg 1998;85:1125-8.
30. Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992;89:1517-22.
31. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399-404.
32. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992;89:1827-31.
33. Uchida T, Ohashi H, Aoki E, et al. Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP). Leukemia 2000;14:207-12.
34. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK. Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab 2003;88:3284-91.
35. Reinhoff WF Jr. Lymphatic vessels of thyroid gland in dog and man. Arch Surg 1931;23:783-804.
36. Namba H, Matsuo K, Fagin JA. Clonal composition of benign and malignant human thyroid tumors. J Clin Invest 1990;86:120-5.
37. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988;318:658-62.
38. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-53.
39. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992;326:737-40.
40. Schneider AB. Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am 1990;19:495-508.